InVivoMAb anti-rat CD2
BE0417
ApplicationsWestern Blot, Neutralisation/Blocking
Product group Antibodies
ReactivityRat
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-rat CD2
- Delivery Days Customer7
- ApplicationsWestern Blot, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDOX-34
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG2a
- ReactivityRat
- Reactivity SupplierRat
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Hoffmann JC, Herklotz C, Zeidler H, et al. Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34. Ann Rheum Dis. 1997,56(12):716-22.Read this paper
- Hoffmann JC, Herklotz C, Zeidler H, et al. Anti-CD2 (OX34) MoAb treatment of adjuvant arthritic rats: attenuation of established arthritis, selective depletion of CD4+ T cells, and CD2 down-modulation. Clin Exp Immunol. 1997,110(1):63-71.Read this paper
- Seaman WE, Eriksson E, Dobrow R, et al. Inositol trisphosphate is generated by a rat natural killer cell tumor in response to target cells or to crosslinked monoclonal antibody OX-34: possible signaling role for the OX-34 determinant during activation by target cells. Proc Natl Acad Sci U S A. 1987,84(12):4239-43.Read this paper
- He Q, Beyers AD, Barclay AN, et al. A role in transmembrane signaling for the cytoplasmic domain of the CD2 T lymphocyte surface antigen. Cell. 1988,54(7):979-84.Read this paper
